Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Tables)

v3.20.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of fair value assumptions of stock option granted

 

 

Year Ended December 31,

 

 

 

2020

 

 

2019

 

Dividend yield

 

 

0.00 %

 

 

0.00 %

Risk-free interest rate

 

0.28—0.46

%

 

 

1.49 %

Expected term (years)

 

5.65—6.13

 

 

 

5.65

 

Volatility

 

92.51—107.87

%

 

 

93.72 %
Schedule of RSA activity

 

 

Number of

Shares

 

 

Weighted

Average

Grant

Date Fair

Value

 

Unvested, December 31, 2019

 

 

450,000

 

 

$

0.19

 

 

 

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

Released

 

 

(450,000

)

 

 

0.19

 

Unvested, December 31, 2020

 

 

 

 

$

 

Schedule of stock-Based compensation Expense

 

 

 

Year Ended

December 31,

 

   

2020

   

2019

Research and development

 

$ 93,545

 

 

$

General and administrative

 

 

209,197

 

 

 

680,455

 

 

 

$ 302,742

 

 

$ 680,455

 

Stock options | Omnibus Incentive Plan 2014  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of shares available for future grant

 

Shares Available for Grant

Available as of December 31, 2019

13,128,381

Share pool increase

18,394,752

Forfeited

1,837,407

Cancelled

5,830,235

Granted

(26,400,000 )

Available as of December 31, 2020

12,790,775
Schedule of summary of stock option activity

 

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise Price

 

 

Weighted

Average Remaining

Contractual

Term (Years)

 

 

Aggregate

Intrinsic

Value*

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding, December 31, 2019

 

 

3,317,642

 

 

$ 0.33

 

 

 

8.34

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

26,400,000

 

 

 

0.05

 

 

 

 

 

 

 

 

Cancelled

 

 

(5,830,235 )

 

 

0.07

 

 

 

 

 

 

 

 

Forfeited

 

 

(1,837,407 )

 

 

0.26

 

 

 

 

 

 

 

 

Outstanding, December 31, 2020

 

 

22,050,000

 

 

$ 0.06

 

 

 

9.52

 

 

$

 

Exercisable, December 31, 2020

 

 

3,465,000

 

 

$ 0.15

 

 

 

8.88

 

 

$

 

Vested and expected to vest, December 31, 2020

 

 

22,050,000

 

 

$ 0.06

 

 

 

9.52

 

 

$

 

 

*The aggregate intrinsic value is the sum of the amounts by which the quoted market price of the Company’s stock exceeded the exercise price of the stock options at December 31, 2020 for those stock options for which the quoted market price was in excess of the exercise price (“in-the-money options”).